✦ LIBER ✦

Curcumin- and natural extract-loaded nanofibres for potential treatment of lung and breast cancer: in vitro efficacy evaluation

✍ Scribed by Sridhar, Radhakrishnan; Ravanan, Swamy; Venugopal, Jayarama Reddy; Sundarrajan, Subramanian; Pliszka, Damian; Sivasubramanian, S.; Gunasekaran, P.; Prabhakaran, Mohana; Madhaiyan, Kalaipriya; Sahayaraj, Arockia; Lim, Keith Hsiu Chin; Ramakrishna, Seeram

Book ID: 126320808
Publisher: Taylor and Francis Group
Year: 2014
Tongue: English
Weight: 774 KB
Volume: 25
Category: Article
ISSN: 0920-5063
DOI: 10.1080/09205063.2014.917039

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro evaluation of anticancer effect

In vitro evaluation of anticancer effect of Cassia auriculata leaf extract and curcumin through induction of apoptosis in human breast and larynx cancer cell lines

✍ Rajagopalan Prasanna; Harish Chinnakonda Chandramoorthy; Pichai Ramaiyapillai; D 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 627 KB

Development and in vitro characterizatio

Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy

✍ Yadav, Sachin; Gupta, Swati 📂 Article 📅 2013 🏛 Informa UK (Taylor & Francis) 🌐 English ⚖ 730 KB

In vitro screening of crude extracts and

In vitro screening of crude extracts and pure metabolites obtained from marine invertebrates for the treatment of breast cancer

✍ John Stingl; Raymond J. Andersen; Joanne T. Emerman 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 574 KB

14 Evaluation of patient preference for

14 Evaluation of patient preference for oral or intravenous vinorelbine in the treatment of non small cell lung and breast cancer

✍ Shaw, A.; Armitage, M.; Barker, L.; Quinn, J.; Booth, C.; Jeyasangar, G.; Hill, 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 47 KB

RIBBON-2: A Randomized, Double-Blind, Pl

RIBBON-2: A Randomized, Double-Blind, Placebo-Controlled, Phase III Trial Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy for Second-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer

✍ Datko, F.M.; Dickler, M.N. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 295 KB

53 POSTER A phase II, multicenter, rando

53 POSTER A phase II, multicenter, randomized clinical trial to evaluate the efficacy and safety of bevacizumab (Avastin®) in combination with either chemotherapy (docetaxel or pemetrexed) or erlotinib hydrochloride (Tarceva®) compared with chemotherapy alone for treatment of recurrent or refractory non-small cell lung cancer

✍ R. Herbst; V. O'Neill; L. Fehrenbacher; C. Belani; P. Bonomi; L. Hart; O. Melnyk 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB